rs369847561
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_000631.5(NCF4):c.179G>A(p.Arg60His) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000713 in 1,614,012 control chromosomes in the GnomAD database, including 1 homozygotes. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R60C) has been classified as Uncertain significance.
Frequency
Consequence
NM_000631.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
NCF4 | NM_000631.5 | c.179G>A | p.Arg60His | missense_variant | 3/10 | ENST00000248899.11 | |
NCF4-AS1 | NR_147197.1 | n.351+5113C>T | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
NCF4 | ENST00000248899.11 | c.179G>A | p.Arg60His | missense_variant | 3/10 | 1 | NM_000631.5 | P1 | |
NCF4-AS1 | ENST00000619915.1 | n.349+5113C>T | intron_variant, non_coding_transcript_variant | 4 |
Frequencies
GnomAD3 genomes ? AF: 0.0000921 AC: 14AN: 152066Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000557 AC: 14AN: 251336Hom.: 0 AF XY: 0.0000368 AC XY: 5AN XY: 135860
GnomAD4 exome AF: 0.0000691 AC: 101AN: 1461828Hom.: 1 Cov.: 32 AF XY: 0.0000619 AC XY: 45AN XY: 727220
GnomAD4 genome ? AF: 0.0000920 AC: 14AN: 152184Hom.: 0 Cov.: 31 AF XY: 0.0000538 AC XY: 4AN XY: 74394
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Jan 12, 2024 | Variant summary: NCF4 c.179G>A (p.Arg60His) results in a non-conservative amino acid change located in the Phox homology domain of the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 5.6e-05 in 251336 control chromosomes. This frequency is not significantly higher than estimated for a pathogenic variant in NCF4 causing Chronic Granulomatous Disease (5.6e-05 vs 0.00025), allowing no conclusion about variant significance. c.179G>A has been reported in the literature in an individual affected with Crohn's disease in the heterozygous state (Wright_2019). This report does not provide unequivocal conclusions about association of the variant with Chronic Granulomatous Disease. One publication reports experimental evidence evaluating an impact on protein function, however, does not allow convincing conclusions about the variant effect. ClinVar contains an entry for this variant (Variation ID: 539179). Based on the evidence outlined above, the variant was classified as uncertain significance. - |
Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 3 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Invitae | Aug 15, 2022 | This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 60 of the NCF4 protein (p.Arg60His). This variant is present in population databases (rs369847561, gnomAD 0.03%). This missense change has been observed in individual(s) with clinical features of NCF4-related condition (PMID: 31027832). ClinVar contains an entry for this variant (Variation ID: 539179). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Jul 26, 2017 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at